Clinical Trial Update: Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial assessing biological tumor-infiltrating lymphocytes therapy combined with immunotherapy for colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy

Snippet

Sponsor: Essen Biotech | Conditions: Colorectal Cancer, Colon Cancer | Phase 1, Phase 2 | Status: RECRUITING